Valuation: Ipca Laboratories Limited

Market Cap 478B 5.07B 4.59B 4.25B 3.83B 7.22B 7.48B 51.04B 20.24B 255B 19.02B 18.62B 810B P/E 2027 *
31.3x
P/E 2028 * 26.6x
Enterprise Value 468B 4.96B 4.5B 4.16B 3.75B 7.07B 7.32B 49.98B 19.82B 250B 18.63B 18.23B 794B EV / Sales 2027 *
4.22x
EV / Sales 2028 * 3.71x
Free-Float
54.94%
Yield 2027 *
0.32%
Yield 2028 * 0.35%
1 day-0.83%
1 week-2.98%
Current month-2.27%
1 month-1.44%
3 months+8.64%
6 months+18.95%
Current year+32.78%
1 week 1,868.4
Extreme 1868.4
1,991.7
1 month 1,797
Extreme 1797
2,012
Current year 1,391.8
Extreme 1391.8
2,038
1 year 1,361.7
Extreme 1361.7
2,038
3 years 1,041
Extreme 1041
2,038
5 years 669.8
Extreme 669.8
2,038
10 years 200
Extreme 200
2,038
Manager TitleAgeSince
Chief Executive Officer 53 2023-03-31
Chief Executive Officer 70 2023-03-31
Chief Tech/Sci/R&D Officer 52 2023-10-15
Director TitleAgeSince
Chairman 79 2012-07-04
Director/Board Member 53 2008-11-10
Director/Board Member 70 1994-07-31
Date Insider Type Main position Quantity % Market Cap. Importance
12/19/24 Sell 4,000,000 1.5766%
Change 5-day change 1-year change 3-year change Capi.($)
-0.83%-2.98%+27.33%+78.67% 5.07B
+1.26%+6.61%+40.79%+136.32% 1,286B
+0.79%+3.45%+45.84%+93.52% 688B
+0.20%+1.28%+26.97%+113.70% 521B
-0.44%+3.69%+41.45%+68.91% 386B
+0.55%+0.70%+59.02%+44.62% 364B
-0.12%+0.74%+28.39%+58.54% 302B
+0.37%+0.37%+3.33%+37.27% 287B
-0.30%+1.14%+38.29%+72.46% 252B
+0.08%+0.71%+34.44%+124.95% 208B
Average +0.16%+1.57%+34.59%+82.89% 430B
Weighted average by Cap. +0.54%+3.25%+37.69%+96.48%

Financials

2027 *2028 *
Net sales 111B 1.18B 1.07B 986M 890M 1.68B 1.74B 11.85B 4.7B 59.27B 4.42B 4.32B 188B 124B 1.31B 1.19B 1.1B 992M 1.87B 1.94B 13.21B 5.24B 66.07B 4.92B 4.82B 210B
Net income 15.05B 160M 145M 134M 121M 227M 235M 1.61B 637M 8.04B 599M 586M 25.52B 18.02B 191M 173M 160M 145M 272M 282M 1.92B 763M 9.63B 717M 702M 30.55B
Net Debt -9.94B -105M -95.51M -88.34M -79.71M -150M -156M -1.06B -421M -5.31B -396M -387M -16.85B -19.57B -208M -188M -174M -157M -296M -306M -2.09B -829M -10.46B -779M -762M -33.19B
Projected Income Statement - Annual - Ipca Laboratories Limited
Logo Ipca Laboratories Limited
Ipca Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The Company’s products are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing APIs and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc. and Ipca Pharma Nigeria Ltd.
Employees
17,210
Date Price Change Volume
26-11-13 ₹1,884.00 -0.83% 232,739
26-11-12 ₹1,899.70 -2.00% 209,267
26-11-11 ₹1,938.40 -1.09% 248,312
26-11-09 ₹1,959.70 +1.08% 381,272
26-11-08 ₹1,938.70 -0.16% 11,793
Trader
Investor
Global
Quality
ESG MSCI
B
MarketScreener Ratings - Ipca Laboratories Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
1,884.00INR
Average target price
2,074.22INR
Spread / Average Target
+10.10%
  1. Stock Market
  2. Stocks
  3. IPCALAB Stock